CARL Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 19.97%, SMA50 14.99%, SMA200 10.0%). The stock’s 14-day RSI is 65.95 (firm momentum), while the ATR of 0.96 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -15.3% below its high and over 36.71% above its low. Average 10-day trading volume of 155.26 thousand shares is in line with the 3-month average of 157.64 thousand, indicating normal recent market interest.

Wall Street analysts project EPS growth of 19.08% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 8 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $24.00 to $17.00. The high target offers 135.29% upside. The low target suggests 66.67% downside. The mean target is $20.11. This offers 97.16% upside. Carlsmed, Inc. earnings surprise history is a mixed track record. The quarter that ended May 05, 2026, missed forecasts by -25.58%. The prior quarter beat by -25.58%. Over the last six quarters, Apple has recorded several small beats. These include -3.29% in August 28, 2025.

Carlsmed, Inc. has 26.52 million shares outstanding. The public float is 9.70 million shares, elevated short interest at 1.97% of float. This equals 151.59 thousand shares. The short ratio is 1.19 days. Institutional investors hold 0.94% of the float. Insiders own 42.08%. Over the past six months, insider transactions show net selling. They sold 197.86 thousand shares across 1 transactions.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Our AI price prediction model suggests that Carlsmed, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band. Valuation shows Carlsmed, Inc. trading at a premium to the broader market with a P/E of -8.21. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $20.11, suggesting 97.16% upside.

Carlsmed, Inc. (NASDAQ:CARL) closed at $11.15 USD, gaining $0.95 (9.31%) from the previous close of $10.20. The stock is currently mid-range between its 52-week high and low $8.50 and $17.19. With a market capitalization of about $303.11 million, Carlsmed, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~1.97). Key stats such as the average daily volume over the past year has been around 156.55 thousand shares, volume is running light vs its 52-week average. Headquartered in Carlsbad, CA, Carlsmed, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Michael John Cordonnier, the company employs approximately 100 people and listed since April 05, 2018. Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies.

Carlsmed, Inc. trades at a P/E ratio of -8.21, slightly below the S&P 500 average, with a price-to-sales ratio of 4.89 and a price-to-book ratio of 2.95 suggesting the stock is closer to book value. The P/FCF stands at -8.05, also below market averages.